Protagonist Therapeutics Begins Phase 2 Clinical Trial of PTG-300 for Treatment of Patients with Beta Thalassemia » PROTAGONIST THERAPEUTICS, INC. LOGO

Protagonist Therapeutics, Inc. (PRNewsFoto/Protagonist Therapeutics, Inc.)

protagonist-therapeutics-squarelogo-1523876255676

This entry was posted on Thursday, January 10th, 2019 at 7:49 pm and is filed under . You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

Comments are closed.

Secured By miniOrange